Bionano Genomics
Bionano Genomics, Inc. is a biotechnology company focused on genome mapping and analysis. It develops and markets the Saphyr system, an advanced platform designed for ultra-sensitive and specific detection of structural variations in DNA, such as insertions, deletions, and translocations, which are often linked to genetic disorders and diseases, including cancer. The Saphyr system employs optical genome mapping technology, allowing for direct visualization and analysis of long DNA molecules without relying on sequencing. This capability provides researchers and clinicians with critical insights into the structural variations within genomes, enhancing the understanding of disease mechanisms and supporting the development of personalized treatment strategies. Bionano Genomics also offers essential reagents and data solutions, including Bionano prep kits, labeling kits, and software tools for comprehensive experiment management. Its products are primarily sold to academic and governmental research laboratories, as well as pharmaceutical, biotechnology, and contract research organizations across multiple regions, including North America, Europe, and Asia. Founded in 2003 and headquartered in San Diego, California, the company was previously known as BioNano Genomics, Inc. until its name change in July 2018.
Top Stages
3 past transactions
Purigen Biosystems
Acquisition in 2022
Purigen Biosystems, Inc. is a biotechnology company based in Pleasanton, California, specializing in the extraction and purification of nucleic acids from biological samples. Founded in 2012, the company has developed an innovative ionic purification system that employs isotachophoresis, a technique that allows for the efficient separation and quantification of DNA and RNA without the need for physical surface binding. This technology is particularly advantageous for challenging sample types, such as formalin-fixed paraffin-embedded (FFPE) tissues and samples with low cell counts. Purigen's automated platform simplifies the processes of nucleic acid extraction, enrichment, and quantitation, providing researchers with fast and reliable results suitable for applications in qPCR, microarray, and next-generation sequencing (NGS). The company operates as a subsidiary of Agilent Technologies, Inc.
BioDiscovery
Acquisition in 2021
BioDiscovery, Inc., founded in 1997 and based in El Segundo, California, is a scientific software company specializing in genetic research and genomic analysis. The company develops and sells software solutions for analyzing data from high-throughput microarray and next-generation sequencing technologies. Its product suite includes Nexus Copy Number for genetic aberration analysis, Nexus Expression for microarray data analysis, Nexus DB for cloud-based sample querying, ImaGene for image analysis, and NxClinical for clinical case review and reporting. BioDiscovery also offers training and consulting services to support its customers in drug discovery and diagnostics by managing, integrating, and analyzing high-throughput microarray technology data.
Lineagen
Acquisition in 2020
Lineagen, Inc. is a genetic diagnostic company specializing in genetic testing and clinical information services for neurodevelopmental disorders, particularly autism. Founded in 2002 and based in Salt Lake City, Utah, Lineagen offers a range of services including FirstStepDx PLUS, a chromosomal microarray platform designed to identify genomic changes related to autism and other neurodevelopmental conditions, and NextStepDx PLUS, a genetic sequencing test that detects subtle genomic variations. The company also provides M-CHAT.org, an online tool for developmental assessment by healthcare professionals and parents. Lineagen's commitment to improving health outcomes for individuals affected by autism and similar disorders is supported by its access to the Utah Population Database, a resource that enhances its research capabilities in identifying genetic causes and diagnostic pathways for complex diseases. As of August 2020, Lineagen operates as a subsidiary of Bionano Genomics, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.